Financials
- Market Capitalization 331.56 M
- Employee 389
- Founded 1999
- CEO N/A
- Website www.standardbio.com
- Headquarter Delaware, United States
- FIGI BBG000S8WQB6
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.4
Relación precio/flujo de caja
5.73
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2823 | FLGT Fulgent Genetics, Inc. - Common Stock | 20.16 USD | -1.27% | -4.45% | +7.01% | -14.68% | 572.56 M USD | ||
| 2855 | MYGN Myriad Genetics, Inc. - Common Stock | 5.85 USD | -0.17% | -3.15% | +35.73% | -29.26% | 552.52 M USD | ||
| 3298 | PRE Prenetics Global Limited - Class A Ordinary Share | 18.51 USD | -0.91% | +7.12% | -14.58% | +127.12% | 312.34 M USD | ||
| 3586 | BDSX Biodesix, Inc. - Common Stock | 22.19 USD | +3.59% | +3.59% | +39.82% | +77.38% | 224.31 M USD |